ATE269101T1 - Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen - Google Patents

Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen

Info

Publication number
ATE269101T1
ATE269101T1 AT00912431T AT00912431T ATE269101T1 AT E269101 T1 ATE269101 T1 AT E269101T1 AT 00912431 T AT00912431 T AT 00912431T AT 00912431 T AT00912431 T AT 00912431T AT E269101 T1 ATE269101 T1 AT E269101T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
recombinant
inflammations
pulmonary infections
Prior art date
Application number
AT00912431T
Other languages
English (en)
Inventor
Klaus Melchers
Klaus P Schaefer
Wolfram Steinhilber
Jeffrey A Whitsett
Ann Marie Levine
Thomas R Korfhagen
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE269101T1 publication Critical patent/ATE269101T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00912431T 1999-01-19 2000-01-18 Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen ATE269101T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15526899P 1999-01-19 1999-01-19
PCT/EP2000/000324 WO2000043026A2 (en) 1999-01-19 2000-01-18 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation

Publications (1)

Publication Number Publication Date
ATE269101T1 true ATE269101T1 (de) 2004-07-15

Family

ID=22554732

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00912431T ATE269101T1 (de) 1999-01-19 2000-01-18 Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen

Country Status (11)

Country Link
US (2) US7135452B1 (de)
EP (1) EP1173194B1 (de)
AT (1) ATE269101T1 (de)
AU (1) AU774207B2 (de)
CA (1) CA2361276A1 (de)
DE (1) DE60011601T2 (de)
DK (1) DK1173194T3 (de)
ES (1) ES2223478T3 (de)
PT (1) PT1173194E (de)
SI (1) SI1173194T1 (de)
WO (1) WO2000043026A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003530356A (ja) * 2000-04-12 2003-10-14 アルタナ ファルマ アクチエンゲゼルシャフト 急性肺疾患の予防又は早期治療のための肺表面活性物質の新規使用
SE0203591D0 (sv) 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
RU2238757C1 (ru) * 2003-06-24 2004-10-27 ООО "Биосурф" Способ лечения ингаляционных поражений
WO2007111496A1 (en) * 2006-03-28 2007-10-04 Universiteit Utrecht Holding B.V. Improved carbohydrate recognition domains
US20100284969A1 (en) * 2007-06-05 2010-11-11 Frank Guarnieri Methods and Compositions for Delivery of Medicaments to the Lungs
WO2010068754A2 (en) 2008-12-10 2010-06-17 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
EP2637681A4 (de) * 2010-11-04 2015-09-23 Univ Oklahoma Peptidzusammensetzungen zur herunterregulierung des tlr-4-signalweges und verfahren zu ihrer herstellung und verwendung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840527A (en) 1984-12-11 1998-11-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Recombinant alveolar surfactant protein
US4659805A (en) * 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US4912038A (en) * 1984-12-11 1990-03-27 California Biotechnology Inc. Recombinant DNA sequence encoding alveolar surfactant protein
US4882422A (en) * 1985-10-24 1989-11-21 Genetics Institute, Inc. Pulmonary surfactant proteins
WO1988005820A1 (en) * 1987-01-29 1988-08-11 California Biotechnology, Inc. Recombinant alveolar surfactant protein
JP3961029B2 (ja) 1992-06-24 2007-08-15 博 木戸 インフルエンザウィルス感染防止剤
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation

Also Published As

Publication number Publication date
EP1173194A2 (de) 2002-01-23
US20060194732A1 (en) 2006-08-31
CA2361276A1 (en) 2000-07-27
WO2000043026A2 (en) 2000-07-27
WO2000043026A3 (en) 2001-10-18
AU774207B2 (en) 2004-06-17
EP1173194B1 (de) 2004-06-16
ES2223478T3 (es) 2005-03-01
AU3420900A (en) 2000-08-07
DE60011601D1 (de) 2004-07-22
DK1173194T3 (da) 2004-10-18
PT1173194E (pt) 2004-10-29
SI1173194T1 (en) 2004-12-31
DE60011601T2 (de) 2005-07-07
US7135452B1 (en) 2006-11-14

Similar Documents

Publication Publication Date Title
TWI318116B (en) Pharmaceutical compositions for treatment or prophylaxis of viral infections comprising novel aspartyl protease inhibitors and additional anti-viral agents
ATE325614T1 (de) Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen
DK0535091T3 (da) Knogleinducerende farmaceutiske formuleringer
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
ATE481981T1 (de) Behandlung von infektionen des verdauungstrakts mit enzymen
MY151199A (en) Substituted diphenyl heterocycles useful for treating hcv infection
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
DE60042401D1 (de) Fab-i inhibitoren
DE60031974D1 (de) Abgeschwaechte mikroorganismen fuer die behandlung von infektionen
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ATE295174T1 (de) Arzneimittel zur behandlung von bluthochdruck
ATE312079T1 (de) Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
ATE269101T1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
AU4568400A (en) Sphingomyelinase inhibitor
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
FI965114A7 (fi) Farmaseuttinen koostumus virusinfektioiden sekä valinnaisesti tulehdusten estoon ja (tai) hoitoon sekä niiden hoitomenetelmä
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1173194

Country of ref document: EP

REN Ceased due to non-payment of the annual fee